What's New on the FDA Drugs Site
October 2, 2015
- CDER Statement: FDA alerts health care professionals and patients not to use sterile drug products from Chen Shwezin Inc., dba Park Compounding Pharmacy
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- FDA approves Keytruda (pembrolizumab) for advanced non-small cell lung cancer.
- National Drug Code Directory
No hay comentarios:
Publicar un comentario